Bahl & Gaynor’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$465K Sell
2,125
-200
-9% -$43.8K ﹤0.01% 285
2025
Q1
$521K Sell
2,325
-2,039
-47% -$456K ﹤0.01% 284
2024
Q4
$1.43M Sell
4,364
-403
-8% -$132K 0.01% 220
2024
Q3
$1.43M Buy
4,767
+440
+10% +$132K 0.01% 238
2024
Q2
$1.43M Sell
4,327
-649
-13% -$214K 0.01% 228
2024
Q1
$1.97M Buy
4,976
+2,050
+70% +$811K 0.01% 211
2023
Q4
$1.03M Sell
2,926
-214
-7% -$75.4K 0.01% 241
2023
Q3
$1.18M Buy
3,140
+330
+12% +$124K 0.01% 230
2023
Q2
$1.07M Sell
2,810
-237
-8% -$90.6K 0.01% 240
2023
Q1
$1.06M Sell
3,047
-65
-2% -$22.5K 0.01% 237
2022
Q4
$732K Sell
3,112
-297
-9% -$69.9K ﹤0.01% 254
2022
Q3
$839K Sell
3,409
-783
-19% -$193K 0.01% 244
2022
Q2
$1.27M Buy
4,192
+786
+23% +$238K 0.01% 241
2022
Q1
$1.4M Sell
3,406
-349
-9% -$143K 0.01% 238
2021
Q4
$1.76M Sell
3,755
-3,142
-46% -$1.47M 0.01% 234
2021
Q3
$2.93M Sell
6,897
-30
-0.4% -$12.7K 0.02% 202
2021
Q2
$2.49M Sell
6,927
-2,024
-23% -$727K 0.02% 220
2021
Q1
$2.52M Sell
8,951
-6,107
-41% -$1.72M 0.02% 219
2020
Q4
$4.27M Buy
15,058
+406
+3% +$115K 0.03% 171
2020
Q3
$4.03M Sell
14,652
-268
-2% -$73.7K 0.03% 160
2020
Q2
$3.39M Sell
14,920
-2,223
-13% -$505K 0.03% 170
2020
Q1
$2.61M Sell
17,143
-615
-3% -$93.6K 0.02% 184
2019
Q4
$2.67M Sell
17,758
-832
-4% -$125K 0.02% 213
2019
Q3
$2.64M Sell
18,590
-284
-2% -$40.3K 0.02% 203
2019
Q2
$2.36M Hold
18,874
0.02% 213
2019
Q1
$2.08M Buy
18,874
+250
+1% +$27.6K 0.02% 207
2018
Q4
$1.83M Sell
18,624
-640
-3% -$62.7K 0.02% 203
2018
Q3
$2.38M Sell
19,264
-6
-0% -$741 0.03% 193
2018
Q2
$1.91M Sell
19,270
-53
-0.3% -$5.26K 0.02% 219
2018
Q1
$1.71M Sell
19,323
-40
-0.2% -$3.53K 0.02% 230
2017
Q4
$1.91M Sell
19,363
-2,075
-10% -$205K 0.02% 221
2017
Q3
$2.06M Sell
21,438
-850
-4% -$81.8K 0.02% 196
2017
Q2
$2.11M Sell
22,288
-27,191
-55% -$2.57M 0.02% 185
2017
Q1
$4.04M Buy
49,479
+3,345
+7% +$273K 0.05% 128
2016
Q4
$3.91M Buy
46,134
+4,044
+10% +$343K 0.05% 129
2016
Q3
$3.14M Buy
42,090
+2,386
+6% +$178K 0.04% 135
2016
Q2
$3.01M Buy
39,704
+2,160
+6% +$164K 0.04% 136
2016
Q1
$2.6M Sell
37,544
-144
-0.4% -$9.98K 0.03% 148
2015
Q4
$2.27M Buy
37,688
+1,365
+4% +$82.2K 0.03% 159
2015
Q3
$1.97M Buy
36,323
+2,755
+8% +$149K 0.03% 171
2015
Q2
$1.95M Sell
33,568
-3,375
-9% -$196K 0.03% 175
2015
Q1
$2.22M Sell
36,943
-2,932
-7% -$177K 0.03% 164
2014
Q4
$2.12M Sell
39,875
-16
-0% -$852 0.03% 172
2014
Q3
$1.79M Buy
39,891
+6,190
+18% +$277K 0.03% 180
2014
Q2
$1.42M Buy
33,701
+18,760
+126% +$792K 0.02% 192
2014
Q1
$658K Buy
14,941
+526
+4% +$23.2K 0.01% 238
2013
Q4
$707K Buy
14,415
+995
+7% +$48.8K 0.01% 226
2013
Q3
$552K Sell
13,420
-80
-0.6% -$3.29K 0.01% 231
2013
Q2
$474K Buy
+13,500
New +$474K 0.01% 233